The Second Affiliated Hospital Of Shandong First Medical University

This study tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab), a targeted therapy (lenvatinib), and a procedure called TACE in people with advanced liver cancer. The goal is to see if this mix can delay cancer growth. About 41 adults who have not had pr…

This study tests a drug called trilaciclib given before chemotherapy to protect bone marrow in people with advanced bile duct or pancreatic cancer. The goal is to reduce severe low white blood cell counts and other blood-related side effects. About 96 adults will take part to see…